Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples
Open Access
- 23 October 2021
- Vol. 13 (21), 5321
- https://doi.org/10.3390/cancers13215321
Abstract
Early detection of pancreatic ductal adenocarcinoma (PDAC) is challenging, and late diagnosis partly explains the low 5-year survival. Novel and sensitive biomarkers are needed to enable early PDAC detection and improve patient outcomes. Tissue polypeptide specific antigen (TPS) has been studied as a biomarker in PDAC diagnostics, and it has previously been shown to reflect clinical status better than the ‘golden standard’ biomarker carbohydrate antigen 19-9 (CA 19-9) that is most widely used in the clinical setting. In this cross-sectional case-control study using pre-diagnostic plasma samples, we aim to evaluate the potential of TPS as a biomarker for early PDAC detection. Furthermore, in a subset of individuals with multiple samples available at different time points before diagnosis, a longitudinal analysis was used. We assessed plasma TPS levels using enzyme-linked immunosorbent assay (ELISA) in 267 pre-diagnostic PDAC plasma samples taken up to 18.8 years before clinical PDAC diagnosis and in 320 matched healthy controls. TPS levels were also assessed in 25 samples at PDAC diagnosis. Circulating TPS levels were low both in pre-diagnostic samples of future PDAC patients and in healthy controls, whereas TPS levels at PDAC diagnosis were significantly increased (odds ratio 1.03; 95% confidence interval: 1.01–1.05) in a logistic regression model adjusted for age. In conclusion, TPS levels increase late in PDAC progression and hold no potential as a biomarker for early detection.Funding Information
- Swedish Research Council (2016-02990, 2019-01690, 2017-01531)
- Swedish Cancer Society (19 0273, 2017-557, CAN 2017/332, CAN 2017/827)
- Västerbotten County (RV-583411, RV-549731, RV-841551, RV-930167, VLL-643451, -)
- The Sjöberg Foundation (-)
- Umea University (-)
- Knut and Alice Wallenberg Foundation (-)
This publication has 33 references indexed in Scilit:
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma developmentNature Medicine, 2014
- Serum tissue polypeptide-specific antigen is an independent predictor in breast cancerActa Histochemica, 2014
- Diagnostic Validity of Serum Macrophage Inhibitor Cytokine and Tissue Polypeptide-Specific Antigen in Pancreatobiliary DiseasesPancreatology, 2011
- Clinical Value of Serum Neopterin, Tissue Polypeptide-Specific Antigen and CA19-9 Levels in Differential Diagnosis between Pancreatic Cancer and Chronic PancreatitisPancreatology, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Diagnostic Value of Tissue Polypeptide Specific Antigen in Patients with Pancreatic CarcinomaTumor Biology, 1994
- Clinical Utility of TPS, TPA and CA 19-9 Measurement in Pancreatic CancerOncology, 1993
- Specific Antigen in Serum of Patients with Colon CarcinomaScience, 1981
- Colorectal carcinoma antigens detected by hybridoma antibodiesSomatic Cell and Molecular Genetics, 1979